版本:
中国

BRIEF-GSK files regulatory submission in U.S. for COPD treatment

Nov 21 Glaxosmithkline Plc

* Files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with copd

* This follows announcement earlier this year of plans to bring forward timing of us filing from first half of 2018. Source text for Eikon: Further company coverage: (Reporting By UK Bureau)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐